These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32714743)

  • 1. Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing.
    Yin H; Yuan X; Luo L; Lu Y; Qin B; Zhang J; Shi Y; Zhu C; Yang J; Li X; Jiang M; Luo Z; Shan X; Chen D; You J
    Adv Sci (Weinh); 2020 Jul; 7(14):1903381. PubMed ID: 32714743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting DNA to the endoplasmic reticulum efficiently enhances gene delivery and therapy.
    Qin B; Yuan X; Jiang M; Yin H; Luo Z; Zhang J; Zhu C; Li X; Shi Y; Luo L; Du Y; You J
    Nanoscale; 2020 Sep; 12(35):18249-18262. PubMed ID: 32857088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-like Nonvirus Cationic Liposome for Efficient Gene Delivery via Endoplasmic Reticulum Pathway.
    Yuan X; Qin B; Yin H; Shi Y; Jiang M; Luo L; Luo Z; Zhang J; Li X; Zhu C; Du Y; You J
    ACS Cent Sci; 2020 Feb; 6(2):174-188. PubMed ID: 32123735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes.
    Sousa DA; Gaspar R; Ferreira CJO; Baltazar F; Rodrigues LR; Silva BFB
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing.
    Xiu K; Saunders L; Wen L; Ruan J; Dong R; Song J; Yang D; Zhang J; Xu J; Chen YE; Ma PX
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9
    Wu Z; Huo X; Yang T; Liu K; Wu T; Feng Z; Wang M; Li F; Jia J; Zhang X; Gao W; Yu L
    Front Oncol; 2022; 12():978533. PubMed ID: 36119467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
    Liu C; Zhang L; Liu H; Cheng K
    J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing.
    Duan L; Ouyang K; Xu X; Xu L; Wen C; Zhou X; Qin Z; Xu Z; Sun W; Liang Y
    Front Genet; 2021; 12():673286. PubMed ID: 34054927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus Oncogene Manipulation Using Clustered Regularly Interspersed Short Palindromic Repeats/Cas9 Delivered by pH-Sensitive Cationic Liposomes.
    Zhen S; Liu Y; Lu J; Tuo X; Yang X; Chen H; Chen W; Li X
    Hum Gene Ther; 2020 Mar; 31(5-6):309-324. PubMed ID: 31973584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 Toolkit for Genome Editing in an Autotrophic CO
    Li J; Zhang L; Xu Q; Zhang W; Li Z; Chen L; Dong X
    Microbiol Spectr; 2022 Aug; 10(4):e0116522. PubMed ID: 35766512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of delivery methods for CRISPR-Cas9.
    Yang W; Yan J; Zhuang P; Ding T; Chen Y; Zhang Y; Zhang H; Cui W
    Expert Opin Drug Deliv; 2022 Aug; 19(8):913-926. PubMed ID: 35818792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System.
    Aksoy YA; Yang B; Chen W; Hung T; Kuchel RP; Zammit NW; Grey ST; Goldys EM; Deng W
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52433-52444. PubMed ID: 33174413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies and Methods for Improving the Efficiency of CRISPR/Cas9 Gene Editing in Plant Molecular Breeding.
    Zhou J; Luan X; Liu Y; Wang L; Wang J; Yang S; Liu S; Zhang J; Liu H; Yao D
    Plants (Basel); 2023 Mar; 12(7):. PubMed ID: 37050104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems.
    Mao Y; Yang X; Zhou Y; Zhang Z; Botella JR; Zhu JK
    Genome Biol; 2018 Sep; 19(1):149. PubMed ID: 30266091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
    Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
    Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.